189 related articles for article (PubMed ID: 16022676)
1. Voltage gated calcium channels as targets for analgesics.
Bourinet E; Zamponi GW
Curr Top Med Chem; 2005; 5(6):539-46. PubMed ID: 16022676
[TBL] [Abstract][Full Text] [Related]
2. Targeting Ca2+ channels to treat pain: T-type versus N-type.
Altier C; Zamponi GW
Trends Pharmacol Sci; 2004 Sep; 25(9):465-70. PubMed ID: 15559248
[TBL] [Abstract][Full Text] [Related]
3. Targeting N-type and T-type calcium channels for the treatment of pain.
McGivern JG
Drug Discov Today; 2006 Mar; 11(5-6):245-53. PubMed ID: 16580601
[TBL] [Abstract][Full Text] [Related]
4. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.
Zamponi GW; Striessnig J; Koschak A; Dolphin AC
Pharmacol Rev; 2015 Oct; 67(4):821-70. PubMed ID: 26362469
[TBL] [Abstract][Full Text] [Related]
5. Scaffold-based design and synthesis of potent N-type calcium channel blockers.
Zamponi GW; Feng ZP; Zhang L; Pajouhesh H; Ding Y; Belardetti F; Pajouhesh H; Dolphin D; Mitscher LA; Snutch TP
Bioorg Med Chem Lett; 2009 Nov; 19(22):6467-72. PubMed ID: 19815411
[TBL] [Abstract][Full Text] [Related]
6. T-type voltage-gated calcium channels as targets for the development of novel pain therapies.
Todorovic SM; Jevtovic-Todorovic V
Br J Pharmacol; 2011 Jun; 163(3):484-95. PubMed ID: 21306582
[TBL] [Abstract][Full Text] [Related]
7. Voltage-gated calcium channels as targets for the treatment of chronic pain.
McGivern JG; McDonough SI
Curr Drug Targets CNS Neurol Disord; 2004 Dec; 3(6):457-78. PubMed ID: 15578964
[TBL] [Abstract][Full Text] [Related]
8. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL
J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
[TBL] [Abstract][Full Text] [Related]
9. T-type calcium channels in chronic pain: mouse models and specific blockers.
François A; Laffray S; Pizzoccaro A; Eschalier A; Bourinet E
Pflugers Arch; 2014 Apr; 466(4):707-17. PubMed ID: 24590509
[TBL] [Abstract][Full Text] [Related]
10. Huwentoxin-XVI, an analgesic, highly reversible mammalian N-type calcium channel antagonist from Chinese tarantula Ornithoctonus huwena.
Deng M; Luo X; Xiao Y; Sun Z; Jiang L; Liu Z; Zeng X; Chen H; Tang J; Zeng W; Songping Liang
Neuropharmacology; 2014 Apr; 79():657-67. PubMed ID: 24467846
[TBL] [Abstract][Full Text] [Related]
11. Voltage-Gated Ion Channels in the PNS: Novel Therapies for Neuropathic Pain?
Tibbs GR; Posson DJ; Goldstein PA
Trends Pharmacol Sci; 2016 Jul; 37(7):522-542. PubMed ID: 27233519
[TBL] [Abstract][Full Text] [Related]
12. 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo.
Todorovic SM; Pathirathna S; Brimelow BC; Jagodic MM; Ko SH; Jiang X; Nilsson KR; Zorumski CF; Covey DF; Jevtovic-Todorovic V
Mol Pharmacol; 2004 Nov; 66(5):1223-35. PubMed ID: 15280444
[TBL] [Abstract][Full Text] [Related]
13. T-type Ca2+ channels as therapeutic targets in the nervous system.
Shin HS; Cheong EJ; Choi S; Lee J; Na HS
Curr Opin Pharmacol; 2008 Feb; 8(1):33-41. PubMed ID: 18203662
[TBL] [Abstract][Full Text] [Related]
14. Regulation of T-type calcium channels in the peripheral pain pathway.
Todorovic SM; Jevtovic-Todorovic V
Channels (Austin); 2007; 1(4):238-45. PubMed ID: 18708751
[TBL] [Abstract][Full Text] [Related]
15. Voltage-gated calcium channels in chronic pain: emerging role of alternative splicing.
Swayne LA; Bourinet E
Pflugers Arch; 2008 Jun; 456(3):459-66. PubMed ID: 18389277
[TBL] [Abstract][Full Text] [Related]
16. T-type calcium channels in neuropathic pain.
Bourinet E; Francois A; Laffray S
Pain; 2016 Feb; 157 Suppl 1():S15-S22. PubMed ID: 26785151
[TBL] [Abstract][Full Text] [Related]
17. Role of voltage-gated calcium channels in epilepsy.
Zamponi GW; Lory P; Perez-Reyes E
Pflugers Arch; 2010 Jul; 460(2):395-403. PubMed ID: 20091047
[TBL] [Abstract][Full Text] [Related]
18. Voltage gated sodium and calcium channel blockers for the treatment of chronic inflammatory pain.
Rahman W; Dickenson AH
Neurosci Lett; 2013 Dec; 557 Pt A():19-26. PubMed ID: 23941888
[TBL] [Abstract][Full Text] [Related]
19. Voltage-gated calcium channels and pain.
Cao YQ
Pain; 2006 Dec; 126(1-3):5-9. PubMed ID: 17084979
[No Abstract] [Full Text] [Related]
20. Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.
Gadotti VM; Bladen C; Zhang FX; Chen L; Gündüz MG; Şimşek R; Şafak C; Zamponi GW
Pflugers Arch; 2015 Dec; 467(12):2485-93. PubMed ID: 26286466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
